日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Change in Postpartum Visit and Contraception Rates Pre-COVID-19 to Post-Lockdown in Six U.S. Federally Qualified Health Centers

美国六家联邦认证医疗中心在新冠疫情封锁前后产后就诊率和避孕率的变化

期刊:
影响因子:
doi:10.1089/jwh.2024.0691
Campbell, Rebecca K; Gray, Emma; Caskey, Rachel; Barkowski, Cristina; Wallander Gemkow, Jena; Mohanty, Nivedita; Rankin, Kristin; Haider, Sadia
微生物学
新冠
发表日期：2025
文献求助 收藏

A Mixed Methods Evaluation of a Quality Improvement Model to Optimize Perinatal and Primary Care in the Community Health Setting

采用混合方法评估社区卫生环境中围产期和初级保健质量改进模式

期刊:Annals of Family Medicine
影响因子:5.1
doi:10.1370/afm.3059
Gemkow, Jena Wallander; Van Schyndel, Ashlee; Odom, Renee M; Stoller, Ananya; Masinter, Lisa; Yang, Ta-Yun; Lee King, Patricia A; Holicky, Abigail C; Handler, Arden
发表日期：2024
文献求助 收藏

Linking Inter-professional Newborn and Contraception Care (LINCC) trial: Protocol for a stepped wedge cluster randomized trial to link postpartum contraception care with routine Well-Baby Visits

将跨专业新生儿和避孕护理联系起来（LINCC）试验：将产后避孕护理与常规婴儿保健访视联系起来的阶梯楔形集群随机试验方案

期刊:Contemporary Clinical Trials
影响因子:1.9
doi:10.1016/j.cct.2024.107659
Haider, Sadia; Ott, Emily; Moore, Amy; Rankin, Kristin; Campbell, Rebecca; Mohanty, Nivedita; Gemkow, Jena Wallander; Caskey, Rachel
发表日期：2024
文献求助 收藏

Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers

Eliapixant 是一种选择性 P2X3 受体拮抗剂，用于治疗与神经纤维过敏相关的疾病

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-021-99177-0
Adam J Davenport #, Ioana Neagoe #, Nico Bräuer, Markus Koch, Andrea Rotgeri, Jens Nagel, Alexis Laux-Biehlmann, Frederic Machet, Anne-Marie Coelho, Susan Boyce, Nikisha Carty, Mark J Gemkow, Stephen D Hess, Thomas M Zollner, Oliver M Fischer
神经
发表日期：2021
文献求助 收藏